Growth Metrics

Eli Lilly (LLY) Buildings (2016 - 2024)

Eli Lilly filings provide 13 years of Buildings readings, the most recent being $8.8 billion for Q4 2024.

  • On a quarterly basis, Buildings rose 6.36% to $8.8 billion in Q4 2024 year-over-year; TTM through Dec 2024 was $8.8 billion, a 6.36% increase, with the full-year FY2024 number at $8.8 billion, up 6.36% from a year prior.
  • Buildings hit $8.8 billion in Q4 2024 for Eli Lilly, up from $8.3 billion in the prior quarter.
  • In the past five years, Buildings ranged from a high of $8.8 billion in Q4 2024 to a low of $7.3 billion in Q4 2020.
  • Median Buildings over the past 5 years was $7.9 billion (2022), compared with a mean of $8.0 billion.
  • Biggest five-year swings in Buildings: grew 3.58% in 2021 and later grew 6.36% in 2024.
  • Eli Lilly's Buildings stood at $7.3 billion in 2020, then increased by 3.58% to $7.6 billion in 2021, then increased by 4.32% to $7.9 billion in 2022, then rose by 4.6% to $8.3 billion in 2023, then grew by 6.36% to $8.8 billion in 2024.
  • The last three reported values for Buildings were $8.8 billion (Q4 2024), $8.3 billion (Q4 2023), and $7.9 billion (Q4 2022) per Business Quant data.